Xiang Li

11PUBLICATIONS
8CO-AUTHORS
Metabolic medicineBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsFree radical chemistryChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 16, 2026
Discovery of Potent and Selective THRβ Agonists Based on an N-Benzoylglycine Scaffold for the Treatment of Metabolic Disorders.

|May 27, 2026
Lysine-Targeted Covalent Inhibitors: Emerging Warheads and Expanding Applications in Medicinal Chemistry.

|Nov 21, 2025
Discovery of 3-(Arylamido)pyrazolopyridine HIF-2α Agonists and a Codrug Strategy with Prolyl Hydroxylase Inhibition for Synergistic Treatment of Renal Anemia.

Yinli Gao, Qingyun Yang, Simeng Liu

|Jul 11, 2025
Machine-Learning-Driven Discovery of N-Phenylbenzenesulfonamides as a Novel Chemotype for Lactate Dehydrogenase A Inhibition with Anti-Pancreatic Cancer Activity.

Qijie Gong, Ying Dong, Jiaqi Liang

|May 09, 2025
Light-Induced, Lysine-Targeting Irreversible Covalent Inhibition of the Human Oxygen Sensing Hydroxylase Factor Inhibiting HIF (FIH).

Yue Wu, Zhihong Li, Samanpreet Kaur

|Oct 21, 2024
Discovery of ZG-2305, an Orally Bioavailable Factor Inhibiting HIF Inhibitor for the Treatment of Obesity and Fatty Liver Disease.

Yue Wu, Zewei Zhang, Haiping Cai

Pageof 2

Frequent Collaborators

9 joint publications

Xiaojin Zhang

7 joint publications

Yue Wu

6 joint publications

Fulai Yang

3 joint publications

Zhihong Li